Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(15):1208-1209; doi:10.1093/jnci/92.15.1208
© 2000 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 15, 1208-1209, August 2, 2000
© 2000 Oxford University Press


NEWS

Awards, Appointments, Announcements

Carl Kupfer, M.D., the only person ever to serve as director of the National Eye Institute at the National Institutes of Health, stepped down from his position July 15 after 30 years of service.



View larger version (127K):
[in this window]
[in a new window]
 
Dr. Carl Kupfer

 
After Congress established the National Eye Institute in 1968, Kupfer was appointed its first director in January 1970. Early on, Kupfer established an Office of Biometry and Epidemiology and launched the landmark Diabetic Retinopathy Study, setting a standard for modern clinical trials in vision research. As NEI Director, Kupfer also oversaw the development of the NEI’s National Eye Health Education Program, a partnership of about 60 professional, civic, and voluntary organizations and government agencies concerned with eye health.

Kupfer will now devote his time to completing a catalog of the Cogan Collection, a compilation of clinical cases and pathology reports of more than 50,000 patients. He will also continue to see patients as part of his clinical research activities at the NIH Clinical Center.

Two Join Roswell Staff

Protul A. Shrikant, Ph.D., and James L. Clements, Ph.D., have joined the staff of the Department of Immunology at Roswell Park Cancer Institute, Buffalo, N.Y.

Shrikant was previously at the Center for Immunology at the University of Minnesota, where he spent 4 years as a Fellow of the National Multiple Sclerosis Society. His research focuses on characterizing aberrant immune reactivity in disease conditions and developing a unique syngeneic tumor model system for investigations into the nature of immune responses generated by tumor cells.

Clements was previously on the faculty of the Department of Pathology at the University of Pennsylvania. His research interests include defining molecular mechanisms that promote T-lymphocyte development and activation, identifying novel genes that may regulate these processes, and modulating the immune response as a means to alleviate disease states such as cancer and autoimmunity.

Editorial Awards Given

Vinod K. Prasad, M.D., of Memorial Sloan-Kettering Cancer Center, New York, and Bryon D. Johnson, Ph.D., of the Medical College of Wisconsin, Milwaukee, received editorial awards for new investigators based on articles published in Biology of Blood and Marrow Transplantation.

Prasad received the George Santos Award for best clinical science paper for his publication "HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRBI alleles: impact of serological vs. DNA typing for HLA-A and -B loci," published in Vol. 5, No. 2 of Biology of Blood and Marrow Transplantation.

Johnson received the Ernest McCulloch & James Till Award for best basic science paper for "Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets," published in Vol. 5, No. 3 of the same journal.

New Chief Named

John F. DiPersio, M.D., Ph.D., has been named chief of the new Division of Oncology at Washington University School of Medicine, St. Louis.

The new division combines the previous divisions of Medical and Molecular Oncology and Bone Marrow Transplantation and Stem Cell Biology. DiPersio was previously a professor of medicine, pathology, and pediatrics and the Lewis T. and Rosalind B. Apple Chair in Oncology at Barnes-Jewish Hospital, St. Louis.

Jordan Honored

V. Craig Jordan, Ph.D., D.Sc., was presented with an Honorary Fellowship Award of the Faculty of Medicine at University College, Dublin, Ireland.



View larger version (144K):
[in this window]
[in a new window]
 
Dr. V. Craig Jordan

 
Jordan is the Diana, Princess of Wales Professor of Cancer Research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. The award is in recognition of Jordan’s work that resulted in the development of the SERMs tamoxifen and raloxifene for general medical use.

Society Gives Awards

The Society of Nuclear Medicine gave several awards at its June annual business meeting.

Lori Bray Croft, M.D., a clinical instructor in cardiology at Mount Sinai Medical Center, received the second annual SNM-DuPont Pharmaceuticals Fellowship for Research in Women’s Health. The award includes $30,000 for a 1-year fellowship for her research proposal, "The Detection of Abnormal Myocardial Flow Reserve in Women."

Terence Beven, M.D., received the Society President’s Distinguished Service Award. Beven, who is the director of nuclear medicine at Our Lady of the Lake Regional Medical Center, Baton Rouge, La., has served as chair of the Society of Nuclear Medicine’s government relations committee and chairs the Section Council of Nuclear Medicine of the American Medical Association House of Delegates.

Yasuhito Sasaki, M.D., Ph.D., was also a recipient of the President’s Distinguished Service Award. Sasaki, who is the director general for the National Institute of Radiological Sciences in Chiba, Japan, was recognized for his efforts to forge closer ties between the Society of Nuclear Medicine and the Japanese Society of Nuclear Medicine.

ACS Honors Caregivers

The American Cancer Society presented its Lane W. Adams Excellence in Caring Award at a recent ceremony during the Society’s National Board of Directors meeting in Phoenix, Ariz.

Eleven people were selected from a nationwide competition of caregivers in the cancer field who exemplify compassion and deep regard for human values.

The recipients were:

Jane D’Antoni, a nurse administrator at the Breast Care Center, State University of New York Health Science Center, Syracuse, N.Y.;

Daniel Hummer, the hospital chaplain at Veterans Administration Medical Center, Bay Pines, Fla.;

Gayl Perry, an oncology social worker with the Head and Neck Oncology Service, Massachusetts Eye and Ear Infirmary, Boston, Mass.;

R. Prasad Mantravadi, M.D., a radiation oncologist in Fort Wayne, Ind.;

Gail Noller, a psychologist at North Region Mental Health Center, Coon Rapids, Minn.;

Mary O. Schueller, a cancer care nurse at St. Nicholas Hospital, Sheboygan, Wis.;

Paul Wayne Sperduto, M.D., of Methodist and Fairview Southdale Hospitals, Minneapolis;

Ian L. Thompson, M.D., a radiation oncologist at Community Cancer Center, Bellingham, Wash.;

Kathy Selvaggi, M.D., medical director of the Richard G. Laube Cancer Center, Armstrong County Memorial Hospital, Kittanning, Pa.;

Sarah L. Spagnola, director of residential living at Johns Hopkins Oncology Center, Baltimore;

Deanna Xistris, director of nursing at the Carl and Dorothy Bennett Cancer Center, Stamford, Conn.

Adams was the long-time executive vice president of the American Cancer Society.

Candidates Sought

The Cure for Lymphoma Foundation is seeking candidates for its 2-year fellowship grant program. The fellowship is intended to encourage careers in lymphoma translational and clinical research. Research may be laboratory or clinic based, but the results and conclusions must be relevant to the treatment of lymphoma.

The fellowships provide a salary of $45,000 the first year and $50,000 the second year, and $5,000 each year for the research project. Candidates must be fellows or junior faculty at or below the level of assistant professor at the start of the award period and hold an M.D., Ph.D., or equivalent degree.

The application deadline is Oct. 2. For applications or further information contact: Fran Morris, Cure for Lymphoma Foundation, 215 Lexington Ave., New York, NY 10016; phone: 212-213-9595; fax: 212-213-1987; e-mail: fmorris{at}cfl.org.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?